nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—POLD1—uterine cancer	0.423	0.715	CbGaD
Gemcitabine—RRM2—uterine cancer	0.168	0.285	CbGaD
Gemcitabine—ABCC10—Etoposide—uterine cancer	0.0717	0.452	CbGbCtD
Gemcitabine—ABCC10—Doxorubicin—uterine cancer	0.0489	0.308	CbGbCtD
Gemcitabine—ABCB1—Progesterone—uterine cancer	0.0149	0.0941	CbGbCtD
Gemcitabine—ABCB1—Dactinomycin—uterine cancer	0.0118	0.0746	CbGbCtD
Gemcitabine—ABCB1—Etoposide—uterine cancer	0.00668	0.0421	CbGbCtD
Gemcitabine—ABCB1—Doxorubicin—uterine cancer	0.00456	0.0287	CbGbCtD
Gemcitabine—POLD1—oviduct—uterine cancer	0.00425	0.0654	CbGeAlD
Gemcitabine—Cytarabine—POLD1—uterine cancer	0.00265	1	CrCbGaD
Gemcitabine—POLD1—exocrine gland—uterine cancer	0.00245	0.0378	CbGeAlD
Gemcitabine—SLC28A1—renal system—uterine cancer	0.00149	0.0229	CbGeAlD
Gemcitabine—POLD1—uterine cervix—uterine cancer	0.00106	0.0163	CbGeAlD
Gemcitabine—POLE—myometrium—uterine cancer	0.00102	0.0157	CbGeAlD
Gemcitabine—POLD1—renal system—uterine cancer	0.00099	0.0152	CbGeAlD
Gemcitabine—CDA—uterine cervix—uterine cancer	0.00095	0.0146	CbGeAlD
Gemcitabine—CDA—decidua—uterine cancer	0.000905	0.0139	CbGeAlD
Gemcitabine—POLD1—uterus—uterine cancer	0.000882	0.0136	CbGeAlD
Gemcitabine—POLA1—myometrium—uterine cancer	0.000877	0.0135	CbGeAlD
Gemcitabine—CDA—endometrium—uterine cancer	0.000859	0.0132	CbGeAlD
Gemcitabine—SLC28A3—mammalian vulva—uterine cancer	0.000849	0.0131	CbGeAlD
Gemcitabine—CMPK1—uterine cervix—uterine cancer	0.000845	0.013	CbGeAlD
Gemcitabine—RRM2—myometrium—uterine cancer	0.000837	0.0129	CbGeAlD
Gemcitabine—CDA—mammalian vulva—uterine cancer	0.000831	0.0128	CbGeAlD
Gemcitabine—CMPK1—smooth muscle tissue—uterine cancer	0.000821	0.0126	CbGeAlD
Gemcitabine—CMPK1—decidua—uterine cancer	0.000805	0.0124	CbGeAlD
Gemcitabine—POLD1—female reproductive system—uterine cancer	0.000793	0.0122	CbGeAlD
Gemcitabine—POLE—uterine cervix—uterine cancer	0.000791	0.0122	CbGeAlD
Gemcitabine—CMPK1—renal system—uterine cancer	0.00079	0.0122	CbGeAlD
Gemcitabine—POLE—decidua—uterine cancer	0.000754	0.0116	CbGeAlD
Gemcitabine—POLD1—female gonad—uterine cancer	0.000722	0.0111	CbGeAlD
Gemcitabine—POLE—endometrium—uterine cancer	0.000716	0.011	CbGeAlD
Gemcitabine—CMPK1—uterus—uterine cancer	0.000704	0.0108	CbGeAlD
Gemcitabine—RRM1—myometrium—uterine cancer	0.000696	0.0107	CbGeAlD
Gemcitabine—POLE—mammalian vulva—uterine cancer	0.000692	0.0107	CbGeAlD
Gemcitabine—POLA1—uterine cervix—uterine cancer	0.000682	0.0105	CbGeAlD
Gemcitabine—SLC29A2—female reproductive system—uterine cancer	0.000665	0.0102	CbGeAlD
Gemcitabine—SLC28A3—female gonad—uterine cancer	0.000662	0.0102	CbGeAlD
Gemcitabine—RRM2—uterine cervix—uterine cancer	0.000652	0.01	CbGeAlD
Gemcitabine—POLA1—decidua—uterine cancer	0.00065	0.01	CbGeAlD
Gemcitabine—CDA—vagina—uterine cancer	0.000644	0.00991	CbGeAlD
Gemcitabine—CMPK1—female reproductive system—uterine cancer	0.000633	0.00974	CbGeAlD
Gemcitabine—RRM2—decidua—uterine cancer	0.000621	0.00956	CbGeAlD
Gemcitabine—POLA1—endometrium—uterine cancer	0.000617	0.00949	CbGeAlD
Gemcitabine—RRM2—renal system—uterine cancer	0.00061	0.00938	CbGeAlD
Gemcitabine—SLC29A2—vagina—uterine cancer	0.000602	0.00926	CbGeAlD
Gemcitabine—POLA1—mammalian vulva—uterine cancer	0.000597	0.00918	CbGeAlD
Gemcitabine—POLD1—Danazol—Progesterone—uterine cancer	0.000593	0.275	CbGdCrCtD
Gemcitabine—POLE—female reproductive system—uterine cancer	0.000593	0.00913	CbGeAlD
Gemcitabine—RRM2—endometrium—uterine cancer	0.000589	0.00907	CbGeAlD
Gemcitabine—CMPK1—female gonad—uterine cancer	0.000576	0.00886	CbGeAlD
Gemcitabine—CMPK1—vagina—uterine cancer	0.000572	0.00881	CbGeAlD
Gemcitabine—RRM2—mammalian vulva—uterine cancer	0.00057	0.00878	CbGeAlD
Gemcitabine—SLC29A1—myometrium—uterine cancer	0.000566	0.00871	CbGeAlD
Gemcitabine—RRM2—uterus—uterine cancer	0.000543	0.00836	CbGeAlD
Gemcitabine—RRM1—uterine cervix—uterine cancer	0.000541	0.00833	CbGeAlD
Gemcitabine—DCK—myometrium—uterine cancer	0.00054	0.00832	CbGeAlD
Gemcitabine—POLE—female gonad—uterine cancer	0.00054	0.0083	CbGeAlD
Gemcitabine—POLE—vagina—uterine cancer	0.000536	0.00825	CbGeAlD
Gemcitabine—RRM1—smooth muscle tissue—uterine cancer	0.000526	0.0081	CbGeAlD
Gemcitabine—RRM1—decidua—uterine cancer	0.000516	0.00794	CbGeAlD
Gemcitabine—ABCC10—myometrium—uterine cancer	0.000515	0.00792	CbGeAlD
Gemcitabine—RRM1—renal system—uterine cancer	0.000507	0.0078	CbGeAlD
Gemcitabine—TYMS—uterine cervix—uterine cancer	0.000491	0.00755	CbGeAlD
Gemcitabine—RRM1—endometrium—uterine cancer	0.00049	0.00754	CbGeAlD
Gemcitabine—RRM2—female reproductive system—uterine cancer	0.000488	0.00751	CbGeAlD
Gemcitabine—TYMS—smooth muscle tissue—uterine cancer	0.000477	0.00734	CbGeAlD
Gemcitabine—RRM1—mammalian vulva—uterine cancer	0.000474	0.00729	CbGeAlD
Gemcitabine—POLA1—female gonad—uterine cancer	0.000465	0.00716	CbGeAlD
Gemcitabine—POLD1—lymph node—uterine cancer	0.000464	0.00714	CbGeAlD
Gemcitabine—POLA1—vagina—uterine cancer	0.000462	0.00711	CbGeAlD
Gemcitabine—RRM1—uterus—uterine cancer	0.000451	0.00694	CbGeAlD
Gemcitabine—RRM2—female gonad—uterine cancer	0.000444	0.00684	CbGeAlD
Gemcitabine—TYMS—endometrium—uterine cancer	0.000444	0.00683	CbGeAlD
Gemcitabine—RRM2—vagina—uterine cancer	0.000442	0.0068	CbGeAlD
Gemcitabine—SLC29A1—uterine cervix—uterine cancer	0.00044	0.00677	CbGeAlD
Gemcitabine—TYMS—mammalian vulva—uterine cancer	0.000429	0.00661	CbGeAlD
Gemcitabine—DCK—uterine cervix—uterine cancer	0.000421	0.00647	CbGeAlD
Gemcitabine—SLC29A1—decidua—uterine cancer	0.000419	0.00645	CbGeAlD
Gemcitabine—CDA—lymph node—uterine cancer	0.000416	0.00641	CbGeAlD
Gemcitabine—SLC29A1—renal system—uterine cancer	0.000412	0.00634	CbGeAlD
Gemcitabine—RRM1—female reproductive system—uterine cancer	0.000406	0.00624	CbGeAlD
Gemcitabine—DCK—decidua—uterine cancer	0.000401	0.00617	CbGeAlD
Gemcitabine—ABCC10—uterine cervix—uterine cancer	0.000401	0.00617	CbGeAlD
Gemcitabine—SLC29A1—endometrium—uterine cancer	0.000398	0.00613	CbGeAlD
Gemcitabine—SLC29A2—lymph node—uterine cancer	0.000389	0.00599	CbGeAlD
Gemcitabine—SLC29A1—mammalian vulva—uterine cancer	0.000385	0.00593	CbGeAlD
Gemcitabine—ABCC10—decidua—uterine cancer	0.000382	0.00587	CbGeAlD
Gemcitabine—DCK—endometrium—uterine cancer	0.00038	0.00585	CbGeAlD
Gemcitabine—ABCC10—renal system—uterine cancer	0.000375	0.00577	CbGeAlD
Gemcitabine—CMPK1—lymph node—uterine cancer	0.00037	0.0057	CbGeAlD
Gemcitabine—RRM1—female gonad—uterine cancer	0.000369	0.00568	CbGeAlD
Gemcitabine—DCK—mammalian vulva—uterine cancer	0.000368	0.00566	CbGeAlD
Gemcitabine—TYMS—female reproductive system—uterine cancer	0.000368	0.00566	CbGeAlD
Gemcitabine—SLC29A1—uterus—uterine cancer	0.000367	0.00565	CbGeAlD
Gemcitabine—RRM1—vagina—uterine cancer	0.000367	0.00565	CbGeAlD
Gemcitabine—POLA1—Norethindrone—Progesterone—uterine cancer	0.000367	0.17	CbGdCrCtD
Gemcitabine—ABCC10—endometrium—uterine cancer	0.000362	0.00558	CbGeAlD
Gemcitabine—ABCC10—mammalian vulva—uterine cancer	0.000351	0.00539	CbGeAlD
Gemcitabine—DCK—uterus—uterine cancer	0.00035	0.00539	CbGeAlD
Gemcitabine—POLE—lymph node—uterine cancer	0.000347	0.00534	CbGeAlD
Gemcitabine—TYMS—female gonad—uterine cancer	0.000335	0.00515	CbGeAlD
Gemcitabine—ABCC10—uterus—uterine cancer	0.000334	0.00514	CbGeAlD
Gemcitabine—TYMS—vagina—uterine cancer	0.000333	0.00512	CbGeAlD
Gemcitabine—SLC29A1—female reproductive system—uterine cancer	0.00033	0.00508	CbGeAlD
Gemcitabine—DCK—female reproductive system—uterine cancer	0.000315	0.00485	CbGeAlD
Gemcitabine—ABCC10—female reproductive system—uterine cancer	0.0003	0.00462	CbGeAlD
Gemcitabine—SLC29A1—female gonad—uterine cancer	0.0003	0.00462	CbGeAlD
Gemcitabine—POLA1—lymph node—uterine cancer	0.000299	0.0046	CbGeAlD
Gemcitabine—SLC29A1—vagina—uterine cancer	0.000298	0.00459	CbGeAlD
Gemcitabine—POLA1—Levonorgestrel—Progesterone—uterine cancer	0.000292	0.135	CbGdCrCtD
Gemcitabine—DCK—female gonad—uterine cancer	0.000287	0.00441	CbGeAlD
Gemcitabine—RRM2—lymph node—uterine cancer	0.000286	0.0044	CbGeAlD
Gemcitabine—DCK—vagina—uterine cancer	0.000285	0.00439	CbGeAlD
Gemcitabine—ABCC10—female gonad—uterine cancer	0.000273	0.0042	CbGeAlD
Gemcitabine—ABCC10—vagina—uterine cancer	0.000271	0.00418	CbGeAlD
Gemcitabine—TYMS—Podofilox—Etoposide—uterine cancer	0.000245	0.114	CbGdCrCtD
Gemcitabine—RRM1—lymph node—uterine cancer	0.000237	0.00365	CbGeAlD
Gemcitabine—TYMS—lymph node—uterine cancer	0.000215	0.00331	CbGeAlD
Gemcitabine—SLC29A1—lymph node—uterine cancer	0.000193	0.00297	CbGeAlD
Gemcitabine—DCK—lymph node—uterine cancer	0.000184	0.00284	CbGeAlD
Gemcitabine—ABCC10—lymph node—uterine cancer	0.000176	0.0027	CbGeAlD
Gemcitabine—DCK—Doxorubicin—Epirubicin—uterine cancer	0.00017	0.0786	CbGdCrCtD
Gemcitabine—DCK—Epirubicin—Doxorubicin—uterine cancer	0.000157	0.0728	CbGdCrCtD
Gemcitabine—ABCB1—myometrium—uterine cancer	0.000149	0.00229	CbGeAlD
Gemcitabine—TYMS—Danazol—Progesterone—uterine cancer	0.000126	0.0584	CbGdCrCtD
Gemcitabine—DCK—Levonorgestrel—Progesterone—uterine cancer	0.00012	0.0556	CbGdCrCtD
Gemcitabine—ABCB1—epithelium—uterine cancer	0.000117	0.0018	CbGeAlD
Gemcitabine—ABCB1—uterine cervix—uterine cancer	0.000116	0.00178	CbGeAlD
Gemcitabine—ABCB1—decidua—uterine cancer	0.00011	0.0017	CbGeAlD
Gemcitabine—ABCB1—renal system—uterine cancer	0.000108	0.00167	CbGeAlD
Gemcitabine—Urethral disorder—Etoposide—uterine cancer	0.000105	0.00107	CcSEcCtD
Gemcitabine—ABCB1—endometrium—uterine cancer	0.000105	0.00161	CbGeAlD
Gemcitabine—Infection—Dactinomycin—uterine cancer	0.000105	0.00107	CcSEcCtD
Gemcitabine—Blood urea increased—Doxorubicin—uterine cancer	0.000104	0.00107	CcSEcCtD
Gemcitabine—Neuropathy—Doxorubicin—uterine cancer	0.000104	0.00106	CcSEcCtD
Gemcitabine—Sepsis—Epirubicin—uterine cancer	0.000104	0.00106	CcSEcCtD
Gemcitabine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000103	0.00105	CcSEcCtD
Gemcitabine—Diarrhoea—Progesterone—uterine cancer	0.000102	0.00104	CcSEcCtD
Gemcitabine—Erythema multiforme—Etoposide—uterine cancer	0.000101	0.00103	CcSEcCtD
Gemcitabine—ABCB1—mammalian vulva—uterine cancer	0.000101	0.00156	CbGeAlD
Gemcitabine—Anorexia—Dactinomycin—uterine cancer	0.0001	0.00102	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	9.98e-05	0.00102	CcSEcCtD
Gemcitabine—Cardiac disorder—Etoposide—uterine cancer	9.95e-05	0.00101	CcSEcCtD
Gemcitabine—Hepatic function abnormal—Epirubicin—uterine cancer	9.94e-05	0.00101	CcSEcCtD
Gemcitabine—Pulmonary oedema—Doxorubicin—uterine cancer	9.85e-05	0.001	CcSEcCtD
Gemcitabine—Angiopathy—Etoposide—uterine cancer	9.72e-05	0.000991	CcSEcCtD
Gemcitabine—Immune system disorder—Etoposide—uterine cancer	9.68e-05	0.000987	CcSEcCtD
Gemcitabine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	9.68e-05	0.000987	CcSEcCtD
Gemcitabine—Hepatic failure—Epirubicin—uterine cancer	9.66e-05	0.000985	CcSEcCtD
Gemcitabine—Mediastinal disorder—Etoposide—uterine cancer	9.66e-05	0.000985	CcSEcCtD
Gemcitabine—ABCB1—uterus—uterine cancer	9.64e-05	0.00148	CbGeAlD
Gemcitabine—Chills—Etoposide—uterine cancer	9.62e-05	0.00098	CcSEcCtD
Gemcitabine—Sepsis—Doxorubicin—uterine cancer	9.6e-05	0.000979	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	9.58e-05	0.000977	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Epirubicin—uterine cancer	9.57e-05	0.000976	CcSEcCtD
Gemcitabine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	9.54e-05	0.000973	CcSEcCtD
Gemcitabine—Alopecia—Etoposide—uterine cancer	9.47e-05	0.000966	CcSEcCtD
Gemcitabine—Vomiting—Progesterone—uterine cancer	9.46e-05	0.000965	CcSEcCtD
Gemcitabine—Rash—Progesterone—uterine cancer	9.38e-05	0.000957	CcSEcCtD
Gemcitabine—Dermatitis—Progesterone—uterine cancer	9.38e-05	0.000956	CcSEcCtD
Gemcitabine—Headache—Progesterone—uterine cancer	9.32e-05	0.000951	CcSEcCtD
Gemcitabine—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	9.24e-05	0.000942	CcSEcCtD
Gemcitabine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	9.23e-05	0.000941	CcSEcCtD
Gemcitabine—Hepatic function abnormal—Doxorubicin—uterine cancer	9.19e-05	0.000937	CcSEcCtD
Gemcitabine—Decreased appetite—Dactinomycin—uterine cancer	9.14e-05	0.000932	CcSEcCtD
Gemcitabine—Renal impairment—Epirubicin—uterine cancer	9.12e-05	0.00093	CcSEcCtD
Gemcitabine—Dermatitis bullous—Epirubicin—uterine cancer	9.09e-05	0.000926	CcSEcCtD
Gemcitabine—Fatigue—Dactinomycin—uterine cancer	9.07e-05	0.000925	CcSEcCtD
Gemcitabine—TYMS—Levonorgestrel—Progesterone—uterine cancer	9.05e-05	0.0419	CbGdCrCtD
Gemcitabine—Back pain—Etoposide—uterine cancer	9.02e-05	0.00092	CcSEcCtD
Gemcitabine—Pain—Dactinomycin—uterine cancer	9e-05	0.000917	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Epirubicin—uterine cancer	8.97e-05	0.000915	CcSEcCtD
Gemcitabine—Hepatic failure—Doxorubicin—uterine cancer	8.94e-05	0.000912	CcSEcCtD
Gemcitabine—Cardiac failure—Epirubicin—uterine cancer	8.9e-05	0.000907	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Epirubicin—uterine cancer	8.86e-05	0.000903	CcSEcCtD
Gemcitabine—Cardiac failure congestive—Doxorubicin—uterine cancer	8.86e-05	0.000903	CcSEcCtD
Gemcitabine—Nausea—Progesterone—uterine cancer	8.84e-05	0.000901	CcSEcCtD
Gemcitabine—Feeling abnormal—Dactinomycin—uterine cancer	8.67e-05	0.000884	CcSEcCtD
Gemcitabine—ABCB1—female reproductive system—uterine cancer	8.67e-05	0.00133	CbGeAlD
Gemcitabine—Ill-defined disorder—Etoposide—uterine cancer	8.66e-05	0.000883	CcSEcCtD
Gemcitabine—Anaemia—Etoposide—uterine cancer	8.62e-05	0.000879	CcSEcCtD
Gemcitabine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	8.57e-05	0.000874	CcSEcCtD
Gemcitabine—Rash—Medroxyprogesterone Acetate—uterine cancer	8.5e-05	0.000867	CcSEcCtD
Gemcitabine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	8.5e-05	0.000866	CcSEcCtD
Gemcitabine—Headache—Medroxyprogesterone Acetate—uterine cancer	8.45e-05	0.000861	CcSEcCtD
Gemcitabine—Renal impairment—Doxorubicin—uterine cancer	8.44e-05	0.000861	CcSEcCtD
Gemcitabine—Malaise—Etoposide—uterine cancer	8.41e-05	0.000858	CcSEcCtD
Gemcitabine—Dermatitis bullous—Doxorubicin—uterine cancer	8.41e-05	0.000857	CcSEcCtD
Gemcitabine—Face oedema—Epirubicin—uterine cancer	8.38e-05	0.000855	CcSEcCtD
Gemcitabine—Leukopenia—Etoposide—uterine cancer	8.35e-05	0.000851	CcSEcCtD
Gemcitabine—Body temperature increased—Dactinomycin—uterine cancer	8.32e-05	0.000848	CcSEcCtD
Gemcitabine—Anaphylactoid reaction—Doxorubicin—uterine cancer	8.3e-05	0.000846	CcSEcCtD
Gemcitabine—Cardiac failure—Doxorubicin—uterine cancer	8.23e-05	0.000839	CcSEcCtD
Gemcitabine—Cerebrovascular accident—Doxorubicin—uterine cancer	8.2e-05	0.000836	CcSEcCtD
Gemcitabine—Cough—Etoposide—uterine cancer	8.14e-05	0.00083	CcSEcCtD
Gemcitabine—Blood creatinine increased—Epirubicin—uterine cancer	8.13e-05	0.000829	CcSEcCtD
Gemcitabine—Hypertension—Etoposide—uterine cancer	8.05e-05	0.000821	CcSEcCtD
Gemcitabine—Liver function test abnormal—Epirubicin—uterine cancer	8.02e-05	0.000817	CcSEcCtD
Gemcitabine—Nausea—Medroxyprogesterone Acetate—uterine cancer	8.01e-05	0.000817	CcSEcCtD
Gemcitabine—Chest pain—Etoposide—uterine cancer	7.94e-05	0.00081	CcSEcCtD
Gemcitabine—Hypokalaemia—Epirubicin—uterine cancer	7.9e-05	0.000806	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	7.89e-05	0.000804	CcSEcCtD
Gemcitabine—ABCB1—female gonad—uterine cancer	7.89e-05	0.00121	CbGeAlD
Gemcitabine—Discomfort—Etoposide—uterine cancer	7.85e-05	0.0008	CcSEcCtD
Gemcitabine—ABCB1—vagina—uterine cancer	7.84e-05	0.00121	CbGeAlD
Gemcitabine—Aspartate aminotransferase increased—Epirubicin—uterine cancer	7.82e-05	0.000797	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Epirubicin—uterine cancer	7.82e-05	0.000797	CcSEcCtD
Gemcitabine—Face oedema—Doxorubicin—uterine cancer	7.76e-05	0.000791	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Epirubicin—uterine cancer	7.66e-05	0.000781	CcSEcCtD
Gemcitabine—Anaphylactic shock—Etoposide—uterine cancer	7.61e-05	0.000776	CcSEcCtD
Gemcitabine—Infection—Etoposide—uterine cancer	7.56e-05	0.000771	CcSEcCtD
Gemcitabine—Asthenia—Dactinomycin—uterine cancer	7.55e-05	0.00077	CcSEcCtD
Gemcitabine—Blood creatinine increased—Doxorubicin—uterine cancer	7.53e-05	0.000767	CcSEcCtD
Gemcitabine—Influenza—Epirubicin—uterine cancer	7.5e-05	0.000765	CcSEcCtD
Gemcitabine—Thrombocytopenia—Etoposide—uterine cancer	7.45e-05	0.00076	CcSEcCtD
Gemcitabine—Liver function test abnormal—Doxorubicin—uterine cancer	7.42e-05	0.000756	CcSEcCtD
Gemcitabine—Skin disorder—Etoposide—uterine cancer	7.4e-05	0.000754	CcSEcCtD
Gemcitabine—Hyperhidrosis—Etoposide—uterine cancer	7.36e-05	0.00075	CcSEcCtD
Gemcitabine—Hypokalaemia—Doxorubicin—uterine cancer	7.31e-05	0.000746	CcSEcCtD
Gemcitabine—Anorexia—Etoposide—uterine cancer	7.26e-05	0.00074	CcSEcCtD
Gemcitabine—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	7.23e-05	0.000738	CcSEcCtD
Gemcitabine—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	7.23e-05	0.000738	CcSEcCtD
Gemcitabine—Diarrhoea—Dactinomycin—uterine cancer	7.2e-05	0.000734	CcSEcCtD
Gemcitabine—Pancytopenia—Epirubicin—uterine cancer	7.13e-05	0.000727	CcSEcCtD
Gemcitabine—Hypotension—Etoposide—uterine cancer	7.11e-05	0.000725	CcSEcCtD
Gemcitabine—Alanine aminotransferase increased—Doxorubicin—uterine cancer	7.09e-05	0.000723	CcSEcCtD
Gemcitabine—Neutropenia—Epirubicin—uterine cancer	7.02e-05	0.000716	CcSEcCtD
Gemcitabine—Influenza—Doxorubicin—uterine cancer	6.94e-05	0.000708	CcSEcCtD
Gemcitabine—Paraesthesia—Etoposide—uterine cancer	6.84e-05	0.000697	CcSEcCtD
Gemcitabine—Dyspnoea—Etoposide—uterine cancer	6.79e-05	0.000692	CcSEcCtD
Gemcitabine—Hyperglycaemia—Epirubicin—uterine cancer	6.77e-05	0.00069	CcSEcCtD
Gemcitabine—Somnolence—Etoposide—uterine cancer	6.77e-05	0.00069	CcSEcCtD
Gemcitabine—Pneumonia—Epirubicin—uterine cancer	6.73e-05	0.000686	CcSEcCtD
Gemcitabine—Vomiting—Dactinomycin—uterine cancer	6.69e-05	0.000682	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	6.63e-05	0.000676	CcSEcCtD
Gemcitabine—Rash—Dactinomycin—uterine cancer	6.63e-05	0.000676	CcSEcCtD
Gemcitabine—Decreased appetite—Etoposide—uterine cancer	6.62e-05	0.000675	CcSEcCtD
Gemcitabine—Pancytopenia—Doxorubicin—uterine cancer	6.59e-05	0.000672	CcSEcCtD
Gemcitabine—Renal failure—Epirubicin—uterine cancer	6.58e-05	0.000671	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Etoposide—uterine cancer	6.57e-05	0.00067	CcSEcCtD
Gemcitabine—Fatigue—Etoposide—uterine cancer	6.56e-05	0.000669	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Epirubicin—uterine cancer	6.56e-05	0.000669	CcSEcCtD
Gemcitabine—Stomatitis—Epirubicin—uterine cancer	6.52e-05	0.000665	CcSEcCtD
Gemcitabine—Pain—Etoposide—uterine cancer	6.51e-05	0.000664	CcSEcCtD
Gemcitabine—Constipation—Etoposide—uterine cancer	6.51e-05	0.000664	CcSEcCtD
Gemcitabine—Neutropenia—Doxorubicin—uterine cancer	6.49e-05	0.000662	CcSEcCtD
Gemcitabine—Sweating—Epirubicin—uterine cancer	6.42e-05	0.000654	CcSEcCtD
Gemcitabine—Haematuria—Epirubicin—uterine cancer	6.38e-05	0.000651	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Epirubicin—uterine cancer	6.33e-05	0.000645	CcSEcCtD
Gemcitabine—Feeling abnormal—Etoposide—uterine cancer	6.27e-05	0.00064	CcSEcCtD
Gemcitabine—Hyperglycaemia—Doxorubicin—uterine cancer	6.26e-05	0.000639	CcSEcCtD
Gemcitabine—Nausea—Dactinomycin—uterine cancer	6.25e-05	0.000637	CcSEcCtD
Gemcitabine—Agranulocytosis—Epirubicin—uterine cancer	6.24e-05	0.000637	CcSEcCtD
Gemcitabine—Pneumonia—Doxorubicin—uterine cancer	6.23e-05	0.000635	CcSEcCtD
Gemcitabine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	6.14e-05	0.000626	CcSEcCtD
Gemcitabine—Renal failure—Doxorubicin—uterine cancer	6.09e-05	0.000621	CcSEcCtD
Gemcitabine—Neuropathy peripheral—Doxorubicin—uterine cancer	6.07e-05	0.000619	CcSEcCtD
Gemcitabine—Haemoglobin—Epirubicin—uterine cancer	6.04e-05	0.000616	CcSEcCtD
Gemcitabine—Stomatitis—Doxorubicin—uterine cancer	6.04e-05	0.000615	CcSEcCtD
Gemcitabine—Rhinitis—Epirubicin—uterine cancer	6.02e-05	0.000614	CcSEcCtD
Gemcitabine—Body temperature increased—Etoposide—uterine cancer	6.02e-05	0.000614	CcSEcCtD
Gemcitabine—Haemorrhage—Epirubicin—uterine cancer	6.01e-05	0.000612	CcSEcCtD
Gemcitabine—Pharyngitis—Epirubicin—uterine cancer	5.96e-05	0.000608	CcSEcCtD
Gemcitabine—Sweating—Doxorubicin—uterine cancer	5.94e-05	0.000605	CcSEcCtD
Gemcitabine—Urinary tract disorder—Epirubicin—uterine cancer	5.93e-05	0.000605	CcSEcCtD
Gemcitabine—Oedema peripheral—Epirubicin—uterine cancer	5.92e-05	0.000603	CcSEcCtD
Gemcitabine—Haematuria—Doxorubicin—uterine cancer	5.9e-05	0.000602	CcSEcCtD
Gemcitabine—Connective tissue disorder—Epirubicin—uterine cancer	5.9e-05	0.000602	CcSEcCtD
Gemcitabine—Urethral disorder—Epirubicin—uterine cancer	5.89e-05	0.0006	CcSEcCtD
Gemcitabine—Hepatobiliary disease—Doxorubicin—uterine cancer	5.86e-05	0.000597	CcSEcCtD
Gemcitabine—Agranulocytosis—Doxorubicin—uterine cancer	5.78e-05	0.000589	CcSEcCtD
Gemcitabine—Erythema multiforme—Epirubicin—uterine cancer	5.68e-05	0.000579	CcSEcCtD
Gemcitabine—Haemoglobin—Doxorubicin—uterine cancer	5.59e-05	0.00057	CcSEcCtD
Gemcitabine—Cardiac disorder—Epirubicin—uterine cancer	5.57e-05	0.000568	CcSEcCtD
Gemcitabine—Rhinitis—Doxorubicin—uterine cancer	5.57e-05	0.000568	CcSEcCtD
Gemcitabine—Haemorrhage—Doxorubicin—uterine cancer	5.56e-05	0.000567	CcSEcCtD
Gemcitabine—Pharyngitis—Doxorubicin—uterine cancer	5.52e-05	0.000562	CcSEcCtD
Gemcitabine—Urinary tract disorder—Doxorubicin—uterine cancer	5.49e-05	0.00056	CcSEcCtD
Gemcitabine—Oedema peripheral—Doxorubicin—uterine cancer	5.48e-05	0.000558	CcSEcCtD
Gemcitabine—Asthenia—Etoposide—uterine cancer	5.46e-05	0.000557	CcSEcCtD
Gemcitabine—Connective tissue disorder—Doxorubicin—uterine cancer	5.46e-05	0.000557	CcSEcCtD
Gemcitabine—Angiopathy—Epirubicin—uterine cancer	5.45e-05	0.000556	CcSEcCtD
Gemcitabine—Urethral disorder—Doxorubicin—uterine cancer	5.45e-05	0.000556	CcSEcCtD
Gemcitabine—Immune system disorder—Epirubicin—uterine cancer	5.43e-05	0.000553	CcSEcCtD
Gemcitabine—Mediastinal disorder—Epirubicin—uterine cancer	5.41e-05	0.000552	CcSEcCtD
Gemcitabine—Chills—Epirubicin—uterine cancer	5.39e-05	0.00055	CcSEcCtD
Gemcitabine—Pruritus—Etoposide—uterine cancer	5.39e-05	0.000549	CcSEcCtD
Gemcitabine—Arrhythmia—Epirubicin—uterine cancer	5.37e-05	0.000547	CcSEcCtD
Gemcitabine—Alopecia—Epirubicin—uterine cancer	5.31e-05	0.000541	CcSEcCtD
Gemcitabine—Erythema multiforme—Doxorubicin—uterine cancer	5.26e-05	0.000536	CcSEcCtD
Gemcitabine—Erythema—Epirubicin—uterine cancer	5.23e-05	0.000533	CcSEcCtD
Gemcitabine—Diarrhoea—Etoposide—uterine cancer	5.21e-05	0.000531	CcSEcCtD
Gemcitabine—Cardiac disorder—Doxorubicin—uterine cancer	5.16e-05	0.000526	CcSEcCtD
Gemcitabine—ABCB1—lymph node—uterine cancer	5.07e-05	0.00078	CbGeAlD
Gemcitabine—Back pain—Epirubicin—uterine cancer	5.06e-05	0.000516	CcSEcCtD
Gemcitabine—Angiopathy—Doxorubicin—uterine cancer	5.04e-05	0.000514	CcSEcCtD
Gemcitabine—Immune system disorder—Doxorubicin—uterine cancer	5.02e-05	0.000512	CcSEcCtD
Gemcitabine—Mediastinal disorder—Doxorubicin—uterine cancer	5.01e-05	0.000511	CcSEcCtD
Gemcitabine—Chills—Doxorubicin—uterine cancer	4.99e-05	0.000509	CcSEcCtD
Gemcitabine—Arrhythmia—Doxorubicin—uterine cancer	4.97e-05	0.000506	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle—YWHAE—uterine cancer	4.96e-05	0.000604	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	4.94e-05	0.0006	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—YWHAE—uterine cancer	4.93e-05	0.0006	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKR1B1—uterine cancer	4.93e-05	0.0006	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—STAR—uterine cancer	4.93e-05	0.0006	CbGpPWpGaD
Gemcitabine—Alopecia—Doxorubicin—uterine cancer	4.91e-05	0.000501	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.88e-05	0.000593	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—POLD1—uterine cancer	4.86e-05	0.000591	CbGpPWpGaD
Gemcitabine—POLA1—DNA Replication—CDKN1B—uterine cancer	4.85e-05	0.00059	CbGpPWpGaD
Gemcitabine—Ill-defined disorder—Epirubicin—uterine cancer	4.85e-05	0.000495	CcSEcCtD
Gemcitabine—Vomiting—Etoposide—uterine cancer	4.84e-05	0.000494	CcSEcCtD
Gemcitabine—Erythema—Doxorubicin—uterine cancer	4.84e-05	0.000493	CcSEcCtD
Gemcitabine—Anaemia—Epirubicin—uterine cancer	4.83e-05	0.000493	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	4.81e-05	0.000584	CbGpPWpGaD
Gemcitabine—Rash—Etoposide—uterine cancer	4.8e-05	0.000489	CcSEcCtD
Gemcitabine—Dermatitis—Etoposide—uterine cancer	4.8e-05	0.000489	CcSEcCtD
Gemcitabine—CDA—Metabolism—AKR1C1—uterine cancer	4.78e-05	0.000581	CbGpPWpGaD
Gemcitabine—Headache—Etoposide—uterine cancer	4.77e-05	0.000486	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—YWHAE—uterine cancer	4.77e-05	0.000579	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—RRM2—uterine cancer	4.73e-05	0.000575	CbGpPWpGaD
Gemcitabine—Malaise—Epirubicin—uterine cancer	4.72e-05	0.000481	CcSEcCtD
Gemcitabine—Leukopenia—Epirubicin—uterine cancer	4.68e-05	0.000477	CcSEcCtD
Gemcitabine—Back pain—Doxorubicin—uterine cancer	4.68e-05	0.000477	CcSEcCtD
Gemcitabine—POLA1—G1/S Transition—CDKN1B—uterine cancer	4.67e-05	0.000568	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.65e-05	0.000566	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—STK11—uterine cancer	4.64e-05	0.000564	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CYP19A1—uterine cancer	4.64e-05	0.000564	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—BIRC5—uterine cancer	4.62e-05	0.000562	CbGpPWpGaD
Gemcitabine—Cough—Epirubicin—uterine cancer	4.56e-05	0.000465	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—RRM2—uterine cancer	4.53e-05	0.000551	CbGpPWpGaD
Gemcitabine—Nausea—Etoposide—uterine cancer	4.52e-05	0.000461	CcSEcCtD
Gemcitabine—Hypertension—Epirubicin—uterine cancer	4.51e-05	0.00046	CcSEcCtD
Gemcitabine—Ill-defined disorder—Doxorubicin—uterine cancer	4.49e-05	0.000458	CcSEcCtD
Gemcitabine—TYMS—G1/S Transition—CDKN1B—uterine cancer	4.48e-05	0.000545	CbGpPWpGaD
Gemcitabine—Anaemia—Doxorubicin—uterine cancer	4.47e-05	0.000456	CcSEcCtD
Gemcitabine—Myalgia—Epirubicin—uterine cancer	4.45e-05	0.000454	CcSEcCtD
Gemcitabine—Chest pain—Epirubicin—uterine cancer	4.45e-05	0.000454	CcSEcCtD
Gemcitabine—Arthralgia—Epirubicin—uterine cancer	4.45e-05	0.000454	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	4.45e-05	0.000541	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	4.42e-05	0.000451	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.41e-05	0.000536	CbGpPWpGaD
Gemcitabine—Discomfort—Epirubicin—uterine cancer	4.4e-05	0.000448	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	4.39e-05	0.000534	CbGpPWpGaD
Gemcitabine—Malaise—Doxorubicin—uterine cancer	4.36e-05	0.000445	CcSEcCtD
Gemcitabine—Leukopenia—Doxorubicin—uterine cancer	4.33e-05	0.000442	CcSEcCtD
Gemcitabine—Anaphylactic shock—Epirubicin—uterine cancer	4.27e-05	0.000435	CcSEcCtD
Gemcitabine—Oedema—Epirubicin—uterine cancer	4.27e-05	0.000435	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	4.26e-05	0.000518	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—RRM2—uterine cancer	4.26e-05	0.000517	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—CDKN1B—uterine cancer	4.24e-05	0.000516	CbGpPWpGaD
Gemcitabine—Infection—Epirubicin—uterine cancer	4.24e-05	0.000432	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—RRM2—uterine cancer	4.23e-05	0.000514	CbGpPWpGaD
Gemcitabine—Cough—Doxorubicin—uterine cancer	4.22e-05	0.000431	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	4.21e-05	0.000511	CbGpPWpGaD
Gemcitabine—Nervous system disorder—Epirubicin—uterine cancer	4.19e-05	0.000427	CcSEcCtD
Gemcitabine—Thrombocytopenia—Epirubicin—uterine cancer	4.18e-05	0.000426	CcSEcCtD
Gemcitabine—Hypertension—Doxorubicin—uterine cancer	4.18e-05	0.000426	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2B—uterine cancer	4.17e-05	0.000507	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2B—uterine cancer	4.15e-05	0.000504	CbGpPWpGaD
Gemcitabine—Skin disorder—Epirubicin—uterine cancer	4.15e-05	0.000423	CcSEcCtD
Gemcitabine—CDA—Metabolism—DCN—uterine cancer	4.13e-05	0.000502	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Epirubicin—uterine cancer	4.13e-05	0.000421	CcSEcCtD
Gemcitabine—Arthralgia—Doxorubicin—uterine cancer	4.12e-05	0.00042	CcSEcCtD
Gemcitabine—Chest pain—Doxorubicin—uterine cancer	4.12e-05	0.00042	CcSEcCtD
Gemcitabine—Myalgia—Doxorubicin—uterine cancer	4.12e-05	0.00042	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	4.09e-05	0.000417	CcSEcCtD
Gemcitabine—Discomfort—Doxorubicin—uterine cancer	4.07e-05	0.000415	CcSEcCtD
Gemcitabine—Anorexia—Epirubicin—uterine cancer	4.07e-05	0.000415	CcSEcCtD
Gemcitabine—RRM2—Metabolism—STAR—uterine cancer	4.06e-05	0.000494	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKR1B1—uterine cancer	4.06e-05	0.000494	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—RRM2—uterine cancer	4.05e-05	0.000493	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—STAR—uterine cancer	4.04e-05	0.000491	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKR1B1—uterine cancer	4.04e-05	0.000491	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2B—uterine cancer	4e-05	0.000487	CbGpPWpGaD
Gemcitabine—Hypotension—Epirubicin—uterine cancer	3.99e-05	0.000407	CcSEcCtD
Gemcitabine—Anaphylactic shock—Doxorubicin—uterine cancer	3.95e-05	0.000403	CcSEcCtD
Gemcitabine—Oedema—Doxorubicin—uterine cancer	3.95e-05	0.000403	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	3.94e-05	0.000479	CbGpPWpGaD
Gemcitabine—Infection—Doxorubicin—uterine cancer	3.92e-05	0.0004	CcSEcCtD
Gemcitabine—CDA—Metabolism—CYP11A1—uterine cancer	3.89e-05	0.000473	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Epirubicin—uterine cancer	3.89e-05	0.000396	CcSEcCtD
Gemcitabine—Nervous system disorder—Doxorubicin—uterine cancer	3.87e-05	0.000395	CcSEcCtD
Gemcitabine—RRM1—Metabolism—POLD1—uterine cancer	3.87e-05	0.00047	CbGpPWpGaD
Gemcitabine—Thrombocytopenia—Doxorubicin—uterine cancer	3.87e-05	0.000394	CcSEcCtD
Gemcitabine—Insomnia—Epirubicin—uterine cancer	3.86e-05	0.000394	CcSEcCtD
Gemcitabine—Skin disorder—Doxorubicin—uterine cancer	3.84e-05	0.000391	CcSEcCtD
Gemcitabine—Paraesthesia—Epirubicin—uterine cancer	3.83e-05	0.000391	CcSEcCtD
Gemcitabine—Hyperhidrosis—Doxorubicin—uterine cancer	3.82e-05	0.000389	CcSEcCtD
Gemcitabine—Dyspnoea—Epirubicin—uterine cancer	3.8e-05	0.000388	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—YWHAE—uterine cancer	3.8e-05	0.000462	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKR1B1—uterine cancer	3.79e-05	0.000461	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—STAR—uterine cancer	3.79e-05	0.000461	CbGpPWpGaD
Gemcitabine—Somnolence—Epirubicin—uterine cancer	3.79e-05	0.000387	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	3.77e-05	0.000459	CbGpPWpGaD
Gemcitabine—Anorexia—Doxorubicin—uterine cancer	3.76e-05	0.000384	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—MLH1—uterine cancer	3.75e-05	0.000457	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.75e-05	0.000456	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2B—uterine cancer	3.73e-05	0.000453	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—uterine cancer	3.72e-05	0.000453	CbGpPWpGaD
Gemcitabine—Decreased appetite—Epirubicin—uterine cancer	3.71e-05	0.000378	CcSEcCtD
Gemcitabine—POLD1—Cell Cycle—CDKN2B—uterine cancer	3.71e-05	0.000451	CbGpPWpGaD
Gemcitabine—Hypotension—Doxorubicin—uterine cancer	3.69e-05	0.000376	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Epirubicin—uterine cancer	3.68e-05	0.000376	CcSEcCtD
Gemcitabine—TYMS—Metabolism—NDUFB11—uterine cancer	3.68e-05	0.000447	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SRD5A2—uterine cancer	3.68e-05	0.000447	CbGpPWpGaD
Gemcitabine—Fatigue—Epirubicin—uterine cancer	3.68e-05	0.000375	CcSEcCtD
Gemcitabine—CDA—Metabolism—AKR1C3—uterine cancer	3.68e-05	0.000447	CbGpPWpGaD
Gemcitabine—Pain—Epirubicin—uterine cancer	3.65e-05	0.000372	CcSEcCtD
Gemcitabine—Constipation—Epirubicin—uterine cancer	3.65e-05	0.000372	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—YWHAE—uterine cancer	3.64e-05	0.000442	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKR1C1—uterine cancer	3.62e-05	0.00044	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—BIRC5—uterine cancer	3.6e-05	0.000438	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—INHBA—uterine cancer	3.6e-05	0.000438	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	3.6e-05	0.000367	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—MLH1—uterine cancer	3.6e-05	0.000437	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2B—uterine cancer	3.58e-05	0.000435	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—BIRC5—uterine cancer	3.58e-05	0.000435	CbGpPWpGaD
Gemcitabine—Insomnia—Doxorubicin—uterine cancer	3.57e-05	0.000364	CcSEcCtD
Gemcitabine—Paraesthesia—Doxorubicin—uterine cancer	3.55e-05	0.000362	CcSEcCtD
Gemcitabine—Dyspnoea—Doxorubicin—uterine cancer	3.52e-05	0.000359	CcSEcCtD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	3.52e-05	0.000428	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Epirubicin—uterine cancer	3.52e-05	0.000359	CcSEcCtD
Gemcitabine—Somnolence—Doxorubicin—uterine cancer	3.51e-05	0.000358	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—MTHFR—uterine cancer	3.48e-05	0.000424	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—BIRC5—uterine cancer	3.45e-05	0.00042	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.44e-05	0.000419	CbGpPWpGaD
Gemcitabine—Decreased appetite—Doxorubicin—uterine cancer	3.43e-05	0.00035	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Doxorubicin—uterine cancer	3.41e-05	0.000348	CcSEcCtD
Gemcitabine—Fatigue—Doxorubicin—uterine cancer	3.4e-05	0.000347	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—YWHAE—uterine cancer	3.4e-05	0.000413	CbGpPWpGaD
Gemcitabine—Pain—Doxorubicin—uterine cancer	3.38e-05	0.000344	CcSEcCtD
Gemcitabine—Constipation—Doxorubicin—uterine cancer	3.38e-05	0.000344	CcSEcCtD
Gemcitabine—Body temperature increased—Epirubicin—uterine cancer	3.37e-05	0.000344	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	3.37e-05	0.00041	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.33e-05	0.000405	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—BIRC5—uterine cancer	3.29e-05	0.0004	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Doxorubicin—uterine cancer	3.25e-05	0.000332	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—YWHAE—uterine cancer	3.25e-05	0.000396	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—RRM2—uterine cancer	3.23e-05	0.000392	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	3.22e-05	0.000392	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—BIRC5—uterine cancer	3.22e-05	0.000391	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—BIRC5—uterine cancer	3.2e-05	0.000389	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—POLD1—uterine cancer	3.19e-05	0.000387	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—DCN—uterine cancer	3.13e-05	0.000381	CbGpPWpGaD
Gemcitabine—Body temperature increased—Doxorubicin—uterine cancer	3.12e-05	0.000318	CcSEcCtD
Gemcitabine—POLE—Cell Cycle—BIRC5—uterine cancer	3.09e-05	0.000376	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	3.09e-05	0.000375	CbGpPWpGaD
Gemcitabine—Asthenia—Epirubicin—uterine cancer	3.06e-05	0.000312	CcSEcCtD
Gemcitabine—Pruritus—Epirubicin—uterine cancer	3.02e-05	0.000308	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.98e-05	0.000363	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKR1C1—uterine cancer	2.98e-05	0.000362	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—POLD1—uterine cancer	2.98e-05	0.000362	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKR1C1—uterine cancer	2.96e-05	0.00036	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP11A1—uterine cancer	2.95e-05	0.000359	CbGpPWpGaD
Gemcitabine—Diarrhoea—Epirubicin—uterine cancer	2.92e-05	0.000298	CcSEcCtD
Gemcitabine—CDA—Metabolism—STK11—uterine cancer	2.86e-05	0.000348	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP19A1—uterine cancer	2.86e-05	0.000348	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.86e-05	0.000348	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2B—uterine cancer	2.85e-05	0.000347	CbGpPWpGaD
Gemcitabine—Asthenia—Doxorubicin—uterine cancer	2.83e-05	0.000289	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.82e-05	0.000343	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.81e-05	0.000342	CbGpPWpGaD
Gemcitabine—Pruritus—Doxorubicin—uterine cancer	2.79e-05	0.000285	CcSEcCtD
Gemcitabine—RRM1—Metabolism—AKR1C3—uterine cancer	2.79e-05	0.000339	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKR1C1—uterine cancer	2.78e-05	0.000339	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.75e-05	0.000334	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2B—uterine cancer	2.73e-05	0.000332	CbGpPWpGaD
Gemcitabine—Vomiting—Epirubicin—uterine cancer	2.71e-05	0.000277	CcSEcCtD
Gemcitabine—Diarrhoea—Doxorubicin—uterine cancer	2.7e-05	0.000275	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.7e-05	0.000328	CbGpPWpGaD
Gemcitabine—Rash—Epirubicin—uterine cancer	2.69e-05	0.000274	CcSEcCtD
Gemcitabine—Dermatitis—Epirubicin—uterine cancer	2.69e-05	0.000274	CcSEcCtD
Gemcitabine—Headache—Epirubicin—uterine cancer	2.67e-05	0.000273	CcSEcCtD
Gemcitabine—TYMS—Metabolism—STAR—uterine cancer	2.66e-05	0.000324	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKR1B1—uterine cancer	2.66e-05	0.000324	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—RRM2—uterine cancer	2.64e-05	0.000321	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.63e-05	0.00032	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.62e-05	0.000319	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—uterine cancer	2.62e-05	0.000319	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—DCN—uterine cancer	2.58e-05	0.000314	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—DCN—uterine cancer	2.56e-05	0.000312	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2B—uterine cancer	2.55e-05	0.00031	CbGpPWpGaD
Gemcitabine—Nausea—Epirubicin—uterine cancer	2.53e-05	0.000258	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—PTEN—uterine cancer	2.53e-05	0.000307	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.51e-05	0.000305	CbGpPWpGaD
Gemcitabine—Vomiting—Doxorubicin—uterine cancer	2.51e-05	0.000256	CcSEcCtD
Gemcitabine—Rash—Doxorubicin—uterine cancer	2.49e-05	0.000254	CcSEcCtD
Gemcitabine—Dermatitis—Doxorubicin—uterine cancer	2.49e-05	0.000254	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.48e-05	0.000302	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—RRM2—uterine cancer	2.48e-05	0.000302	CbGpPWpGaD
Gemcitabine—Headache—Doxorubicin—uterine cancer	2.47e-05	0.000252	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—BIRC5—uterine cancer	2.46e-05	0.000299	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2B—uterine cancer	2.44e-05	0.000297	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP11A1—uterine cancer	2.43e-05	0.000295	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP11A1—uterine cancer	2.41e-05	0.000294	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—EP300—uterine cancer	2.41e-05	0.000293	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—DCN—uterine cancer	2.41e-05	0.000293	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—uterine cancer	2.39e-05	0.00029	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.38e-05	0.000289	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—uterine cancer	2.37e-05	0.000288	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—BIRC5—uterine cancer	2.36e-05	0.000287	CbGpPWpGaD
Gemcitabine—Nausea—Doxorubicin—uterine cancer	2.35e-05	0.000239	CcSEcCtD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	2.31e-05	0.000281	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKR1C3—uterine cancer	2.29e-05	0.000279	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—uterine cancer	2.29e-05	0.000278	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKR1C3—uterine cancer	2.28e-05	0.000277	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP11A1—uterine cancer	2.27e-05	0.000276	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—BIRC5—uterine cancer	2.2e-05	0.000268	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—STK11—uterine cancer	2.17e-05	0.000264	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP19A1—uterine cancer	2.17e-05	0.000264	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—MTHFR—uterine cancer	2.15e-05	0.000262	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKR1C3—uterine cancer	2.14e-05	0.000261	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	2.14e-05	0.00026	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—uterine cancer	2.13e-05	0.000259	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—uterine cancer	2.12e-05	0.000258	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1B—uterine cancer	2.11e-05	0.000257	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.11e-05	0.000257	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—BIRC5—uterine cancer	2.11e-05	0.000256	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1B—uterine cancer	2.1e-05	0.000255	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—POLD1—uterine cancer	2.09e-05	0.000254	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—uterine cancer	2.05e-05	0.000249	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1B—uterine cancer	2.03e-05	0.000247	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.02e-05	0.000246	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKR1C1—uterine cancer	1.95e-05	0.000237	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	1.94e-05	0.000236	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.94e-05	0.000236	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTEN—uterine cancer	1.94e-05	0.000236	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1B—uterine cancer	1.89e-05	0.00023	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1B—uterine cancer	1.88e-05	0.000228	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.88e-05	0.000228	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.86e-05	0.000226	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—EP300—uterine cancer	1.85e-05	0.000226	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—EP300—uterine cancer	1.85e-05	0.000225	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—EP300—uterine cancer	1.84e-05	0.000224	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—CXCL8—uterine cancer	1.83e-05	0.000223	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1B—uterine cancer	1.81e-05	0.00022	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	1.81e-05	0.00022	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.8e-05	0.000218	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP19A1—uterine cancer	1.79e-05	0.000217	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—STK11—uterine cancer	1.79e-05	0.000217	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—EP300—uterine cancer	1.78e-05	0.000217	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP19A1—uterine cancer	1.78e-05	0.000216	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—STK11—uterine cancer	1.78e-05	0.000216	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.75e-05	0.000213	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	1.74e-05	0.000212	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—RRM2—uterine cancer	1.74e-05	0.000212	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—uterine cancer	1.72e-05	0.00021	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	1.72e-05	0.000209	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—DCN—uterine cancer	1.69e-05	0.000205	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—STK11—uterine cancer	1.67e-05	0.000203	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP19A1—uterine cancer	1.67e-05	0.000203	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—EP300—uterine cancer	1.66e-05	0.000202	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—EP300—uterine cancer	1.65e-05	0.0002	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—uterine cancer	1.63e-05	0.000198	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—MTHFR—uterine cancer	1.63e-05	0.000198	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—EP300—uterine cancer	1.59e-05	0.000194	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP11A1—uterine cancer	1.59e-05	0.000194	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.58e-05	0.000193	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—uterine cancer	1.56e-05	0.00019	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.52e-05	0.000184	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKR1C3—uterine cancer	1.5e-05	0.000183	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—uterine cancer	1.49e-05	0.000181	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—uterine cancer	1.46e-05	0.000177	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1B—uterine cancer	1.44e-05	0.000176	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—uterine cancer	1.4e-05	0.00017	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—uterine cancer	1.38e-05	0.000168	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PIK3CA—uterine cancer	1.37e-05	0.000166	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MTHFR—uterine cancer	1.34e-05	0.000163	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MTHFR—uterine cancer	1.33e-05	0.000162	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.3e-05	0.000158	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1B—uterine cancer	1.29e-05	0.000157	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—EP300—uterine cancer	1.27e-05	0.000154	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MTHFR—uterine cancer	1.26e-05	0.000153	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1B—uterine cancer	1.24e-05	0.00015	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—EP300—uterine cancer	1.22e-05	0.000148	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTEN—uterine cancer	1.2e-05	0.000146	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—uterine cancer	1.19e-05	0.000144	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—uterine cancer	1.18e-05	0.000143	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—STK11—uterine cancer	1.17e-05	0.000142	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP19A1—uterine cancer	1.17e-05	0.000142	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—EP300—uterine cancer	1.14e-05	0.000139	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—uterine cancer	1.14e-05	0.000139	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NDUFB11—uterine cancer	1.14e-05	0.000138	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SRD5A2—uterine cancer	1.14e-05	0.000138	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—EP300—uterine cancer	1.13e-05	0.000138	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—AKT1—uterine cancer	1.12e-05	0.000136	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.1e-05	0.000133	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—EP300—uterine cancer	1.09e-05	0.000132	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	9.53e-06	0.000116	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTEN—uterine cancer	9.07e-06	0.00011	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	8.82e-06	0.000107	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MTHFR—uterine cancer	8.8e-06	0.000107	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—EP300—uterine cancer	8.65e-06	0.000105	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PIK3CA—uterine cancer	8.45e-06	0.000103	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	8.33e-06	0.000101	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—STAR—uterine cancer	8.21e-06	9.98e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKR1B1—uterine cancer	8.21e-06	9.98e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	8.12e-06	9.88e-05	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—uterine cancer	8.12e-06	9.87e-05	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—uterine cancer	7.78e-06	9.46e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	7.75e-06	9.42e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTEN—uterine cancer	7.47e-06	9.09e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTEN—uterine cancer	7.43e-06	9.03e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	7.34e-06	8.92e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—EP300—uterine cancer	7.13e-06	8.66e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—EP300—uterine cancer	7.08e-06	8.61e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTEN—uterine cancer	6.98e-06	8.49e-05	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—AKT1—uterine cancer	6.9e-06	8.39e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—EP300—uterine cancer	6.66e-06	8.1e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—POLD1—uterine cancer	6.44e-06	7.83e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PIK3CA—uterine cancer	6.4e-06	7.78e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	6.24e-06	7.58e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKR1C1—uterine cancer	6.03e-06	7.33e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	5.73e-06	6.97e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	5.54e-06	6.74e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RRM2—uterine cancer	5.37e-06	6.53e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PIK3CA—uterine cancer	5.27e-06	6.41e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PIK3CA—uterine cancer	5.24e-06	6.37e-05	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—AKT1—uterine cancer	5.23e-06	6.36e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—DCN—uterine cancer	5.21e-06	6.34e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PIK3CA—uterine cancer	4.93e-06	5.99e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP11A1—uterine cancer	4.91e-06	5.97e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTEN—uterine cancer	4.9e-06	5.95e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	4.68e-06	5.69e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—EP300—uterine cancer	4.67e-06	5.68e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKR1C3—uterine cancer	4.64e-06	5.64e-05	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—AKT1—uterine cancer	4.31e-06	5.24e-05	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—AKT1—uterine cancer	4.28e-06	5.2e-05	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—AKT1—uterine cancer	4.02e-06	4.89e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP19A1—uterine cancer	3.61e-06	4.39e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—STK11—uterine cancer	3.61e-06	4.39e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PIK3CA—uterine cancer	3.45e-06	4.2e-05	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—AKT1—uterine cancer	2.82e-06	3.43e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTHFR—uterine cancer	2.72e-06	3.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTEN—uterine cancer	1.51e-06	1.84e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—EP300—uterine cancer	1.44e-06	1.75e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PIK3CA—uterine cancer	1.07e-06	1.3e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—AKT1—uterine cancer	8.71e-07	1.06e-05	CbGpPWpGaD
